224 related articles for article (PubMed ID: 15179005)
1. Pathogenesis, diagnosis and monitoring of residual disease in acute promyelocytic leukaemia.
Reiter A; Lengfelder E; Grimwade D
Acta Haematol; 2004; 112(1-2):55-67. PubMed ID: 15179005
[TBL] [Abstract][Full Text] [Related]
2. Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia.
Reiter A; Saussele S; Grimwade D; Wiemels JL; Segal MR; Lafage-Pochitaloff M; Walz C; Weisser A; Hochhaus A; Willer A; Reichert A; Büchner T; Lengfelder E; Hehlmann R; Cross NC
Genes Chromosomes Cancer; 2003 Feb; 36(2):175-88. PubMed ID: 12508246
[TBL] [Abstract][Full Text] [Related]
3. Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia.
Grimwade D; Lo Coco F
Leukemia; 2002 Oct; 16(10):1959-73. PubMed ID: 12357347
[TBL] [Abstract][Full Text] [Related]
4. Rapid diagnosis of acute promyelocytic leukemia with the PML-RARA fusion gene using a combination of droplet-reverse transcription-polymerase chain reaction and instant-quality fluorescence in situ hybridization.
Shigeto S; Matsuda K; Yamaguchi A; Sueki A; Uehara M; Sugano M; Uehara T; Honda T
Clin Chim Acta; 2016 Jan; 453():38-41. PubMed ID: 26656442
[TBL] [Abstract][Full Text] [Related]
5. Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.
Xiao YH; Miller WH; Warrell RP; Dmitrovsky E; Zelenetz AD
Am J Pathol; 1993 Nov; 143(5):1301-11. PubMed ID: 8238249
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of PML-RARA fusion gene by novel high-speed droplet-reverse transcriptase-polymerase chain reaction: possibility for molecular diagnosis without lagging behind the morphological analyses.
Sueki A; Matsuda K; Taira C; Yamaguchi A; Koeda H; Takagi F; Kobayashi Y; Sugano M; Honda T
Clin Chim Acta; 2013 Jan; 415():276-8. PubMed ID: 23159843
[TBL] [Abstract][Full Text] [Related]
7. The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease.
Mistry AR; Pedersen EW; Solomon E; Grimwade D
Blood Rev; 2003 Jun; 17(2):71-97. PubMed ID: 12642121
[TBL] [Abstract][Full Text] [Related]
8. Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
Iaccarino L; Divona M; Ottone T; Cicconi L; Lavorgna S; Ciardi C; Alfonso V; Travaglini S; Facchini L; Cimino G; Di Bona E; Voso MT; Lo-Coco F
Genes Chromosomes Cancer; 2019 Jan; 58(1):60-65. PubMed ID: 30421475
[TBL] [Abstract][Full Text] [Related]
9. Modified array-based comparative genomic hybridization detects cryptic and variant PML-RARA rearrangements in acute promyelocytic leukemia lacking classic translocations.
Gruver AM; Rogers HJ; Cook JR; Ballif BC; Schultz RA; Batanian JR; Fesler MJ; Tubbs RR
Diagn Mol Pathol; 2013 Mar; 22(1):10-21. PubMed ID: 23370423
[TBL] [Abstract][Full Text] [Related]
10. [Retinoic acid receptor alpha gene in t (15; 17) APL].
Takashima T; Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1363-8. PubMed ID: 1325570
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
Grimwade D; Howe K; Langabeer S; Burnett A; Goldstone A; Solomon E
Leukemia; 1996 Jan; 10(1):61-6. PubMed ID: 8558940
[TBL] [Abstract][Full Text] [Related]
12. Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.
Grimwade D; Jovanovic JV; Hills RK; Nugent EA; Patel Y; Flora R; Diverio D; Jones K; Aslett H; Batson E; Rennie K; Angell R; Clark RE; Solomon E; Lo-Coco F; Wheatley K; Burnett AK
J Clin Oncol; 2009 Aug; 27(22):3650-8. PubMed ID: 19506161
[TBL] [Abstract][Full Text] [Related]
13. How retinoic acid and arsenic transformed acute promyelocytic leukemia therapy.
Korsos V; Miller WH
J Mol Endocrinol; 2022 Nov; 69(4):T69-T83. PubMed ID: 36112505
[TBL] [Abstract][Full Text] [Related]
14. The significance of minimal residual disease in patients with t(15;17).
Grimwade D
Best Pract Res Clin Haematol; 2002 Mar; 15(1):137-58. PubMed ID: 11987921
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR.
Rossi V; Levati L; Biondi A
Methods Mol Med; 2006; 125():115-26. PubMed ID: 16502581
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukaemia and the t(15;17) translocation.
Gillard EF; Solomon E
Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
[TBL] [Abstract][Full Text] [Related]
17. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci.
Hasan SK; Ottone T; Schlenk RF; Xiao Y; Wiemels JL; Mitra ME; Bernasconi P; Di Raimondo F; Stanghellini MT; Marco P; Mays AN; Döhner H; Sanz MA; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2010 Aug; 49(8):726-32. PubMed ID: 20544846
[TBL] [Abstract][Full Text] [Related]
18. Microarray, gene sequencing, and reverse transcriptase-polymerase chain reaction analyses of a cryptic PML-RARA translocation.
Koshy J; Qian YW; Bhagwath G; Willis M; Kelley TW; Papenhausen P
Cancer Genet; 2012 Oct; 205(10):537-40. PubMed ID: 22982005
[TBL] [Abstract][Full Text] [Related]
19. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia with insertion of PML exon 7a and partial deletion of exon 3 of RARA: a novel variant transcript related to aggressive course and not detected with real-time polymerase chain reaction analysis.
Park TS; Kim JS; Song J; Lee KA; Yoon S; Suh B; Lee JH; Lee HJ; Kim JK; Choi JR
Cancer Genet Cytogenet; 2009 Jan; 188(2):103-7. PubMed ID: 19100514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
